Post‐traumatic stress disorder, depression and suicidality in inpatients with substance use disorders

Dore, Glenys; Mills, Katherine L.; Murray, Robin; Teesson, Maree; Farrugia, Philippa

doi:10.1111/j.1465-3362.2011.00314.x

Cited by 74 publications

(65 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast to some [3], but in agreement with others [5,32], the positive PTSD screening in our patients did not differ by gender and there were no differences regarding principle substances of concern and number of substances used. While these differences cannot be explained at present, methodological differences may play a role, since our data rely on retrospective self-report.…”

Section: Discussionsupporting

confidence: 85%

“…Although it may be argued that assessing trauma/ PTSD during early detoxification treatment possesses a risk of over-diagnosing PTSD due to the substantial overlap between symptoms of withdrawal and PTSD [13,37], our results include support for the validity of the early assessment of trauma and PTSD by replicating some well-established associations from previous studies assessing trauma/PTSD mainly in abstinent patients [3,35,36]: PTSD patients had significantly higher PTSD symptoms in all domains, that is, re-experiencing, avoidance, hyperarousal [3], and significantly higher values for depression and general psychopathological burden [32]. In contrast to some [3], but in agreement with others [5,32], the positive PTSD screening in our patients did not differ by gender and there were no differences regarding principle substances of concern and number of substances used.…”

Section: Discussionsupporting

confidence: 83%

“…Specific questions were whether the patients were willing to participate, whether the evaluation would cause obvious distress or psychological harm, and whether our PTSD screening outcomes in early detoxification treatment would be comparable to findings The participation rate in our study was moderate (60.1%) compared, for example, to the participation rate reported by Dore et al [32] (83%). In addition, we observed a much lower participation rate in one center compared to the other two.…”

Section: Discussionmentioning

confidence: 51%

See 2 more Smart Citations

Early Screening for Posttraumatic Stress Disorder in Inpatient Detoxification and Motivation Treatment: Results and Consequences

et al. 2018

View full text Add to dashboard Cite

Aims: Posttraumatic stress disorder (PTSD) is a significant comorbidity in substance use disorders (SUDs). While most studies have addressed trauma/PTSD in abstinent patients, little is known about trauma/PTSD in early detoxification treatment. The current study therefore addresses the systematic evaluation of trauma/PTSD in early inpatient detoxification. Methods: A cross-sectional survey was accomplished in three German-speaking clinics (n = 134) specialized in inpatient detoxification and motivation treatment. All measures are based on self-report using trauma-specific questionnaires and measures for general psychopathological burden. Results: Participation rate was 60.1% and patients did not show clinically obvious psychological distress during or after assessment. DSM-IV traumatic events were reported by 66.4%. Of the total sample, 38.1% screened positive for PTSD, and 14.9% screened positive for subsyndromal PTSD. PTSD patients reported significantly more childhood adversities and significantly higher scores in depression and general psychopathology compared to subsyndromal PTSD and SUD-only patients. Conclusions: Early and systematic evaluation of PTSD in SUD inpatient detoxification treatment is largely safe and yields important information for individual treatment. The high PTSD-rate and the high symptom load in SUD patients during inpatient detoxification treatment highlight the need for a more stringent address of trauma/PTSD in early SUD treatment.

show abstract

Section: Discussionsupporting

confidence: 85%

Section: Discussionsupporting

confidence: 83%

Section: Discussionmentioning

confidence: 51%

See 1 more Smart Citation

Early Screening for Posttraumatic Stress Disorder in Inpatient Detoxification and Motivation Treatment: Results and Consequences

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Overall, 38.3% of the sample met criteria for a probable PTSD diagnosis. This is consistent with existing research demonstrating that addiction treatment-seeking individuals with SUDs are a highly traumatized population (Dore, Mills, Murray, Teesson, & Farrugia, 2012;Hien, Nunes, Levin, & Fraser, 2000;Wasserman, Havassy, & Boles, 1997).…”

Section: Descriptive Statisticssupporting

confidence: 91%

Examining the relationships between posttraumatic stress disorder symptoms, positive smoking outcome expectancies, and cigarette smoking in people with substance use disorders: A multiple mediator model

Hruska

2014

Addictive Behaviors

View full text Add to dashboard Cite

Cigarette smoking is highly prevalent in people with substance use disorders (SUDs) and is associated with significant physical health problems. Posttraumatic stress disorder (PTSD) is also highly associated with both SUDs and cigarette smoking and may serve as a barrier to smoking cessation efforts. In addition, people with PTSD are more likely to hold positive smoking outcome expectancies (i.e., beliefs that smoking cigarettes results in positive outcomes); these beliefs may contribute to cigarette smoking in people with SUDs experiencing PTSD symptoms. The present study examined the relationship between PTSD symptoms and typical daily cigarette smoking/cigarette dependence symptoms in a sample of 227 trauma-exposed current smokers with SUDs (59.9% male, 89.4% Caucasian) seeking detoxification treatment services. Additionally, the indirect effects of multiple types of positive smoking outcome expectancies on these relationships were examined. Participants completed questionnaires assessing PTSD symptoms, positive smoking outcome expectancies, cigarette consumption, and cigarette dependence symptoms. Results indicated that PTSD symptoms were not directly related to cigarette consumption or cigarette dependence symptoms. However, negative affect reduction outcome expectancies were shown to have a significant indirect effect between PTSD symptoms and cigarette consumption, while negative affect reduction, boredom reduction, and taste-sensorimotor manipulation outcome expectancies were all found to have significant indirect effects between PTSD symptoms and cigarette dependence symptoms. The indirect effect involving negative affect reduction outcome expectancies was statistically larger than that of taste sensorimotor manipulation outcome expectancies, while negative affect reduction and boredom reduction outcome expectancies were comparable in magnitude. These results suggest that expectancies that smoking can manage negative affective experiences are related to cigarette smoking in people with SUDs experiencing PTSD symptoms and suggest that effective smoking cessation treatments should take into account these expectancies.

show abstract

“…Posttraumatic stress disorder (PTSD) has been found to co-occur with substance use disorders, and when co-morbid, results in more negative treatment outcomes (35–50). Research has found particularly high comorbidity between PTSD and opioid use disorders, relative to alcohol and other drugs (44,51,52).…”

Section: Introductionmentioning

confidence: 99%

Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity

Meier¹,

Lambert-Harris²,

McGovern³

et al. 2014

The American Journal of Drug and Alcohol Abuse

View full text Add to dashboard Cite

Background-Prescription opioids are the most rapidly growing category of abused substances, and result in significant morbidity, mortality and healthcare costs. Co-occurring with psychiatric disorders, persons with prescription opioid problems have negative treatment outcomes. Data are needed on the prevalence of co-occurring prescription opioid abuse and specific disorders, such as posttraumatic stress disorder (PTSD), to better inform clinical practice. Objective: To determine prevalence rates of current co-occurring prescription opioid use problems and PTSD symptom severity among patients in community addiction treatment settings.

show abstract

Post‐traumatic stress disorder, depression and suicidality in inpatients with substance use disorders

Abstract: Patients entering treatment for SUDs should be assessed for PTSD, depression and suicidality. These conditions impact significantly on treatment outcomes, and require the development of appropriate treatment strategies.

Cited by 74 publications

References 26 publications

Early Screening for Posttraumatic Stress Disorder in Inpatient Detoxification and Motivation Treatment: Results and Consequences

Early Screening for Posttraumatic Stress Disorder in Inpatient Detoxification and Motivation Treatment: Results and Consequences

Examining the relationships between posttraumatic stress disorder symptoms, positive smoking outcome expectancies, and cigarette smoking in people with substance use disorders: A multiple mediator model

Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity

Contact Info

Product

Resources

About